CeNeS Pharmaceuticals
As part of its restructuring plan, UK biopharmaceutical company CeNeS Pharmaceuticals, of Cambridge, has agreed to sell its chemical library of ion channel blockers to Scion Pharmaceuticals.
As part of its restructuring plan, UK biopharmaceutical company CeNeS Pharmaceuticals, of Cambridge, has agreed to sell its chemical library of ion channel blockers to Scion Pharmaceuticals.